Alan Barge

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

Norbert Schmitz, Peter Dreger, David C. Linch et al. · The Lancet · 1996 · 617 citations

Medicine, Hematology, Oncology +14

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz et al. · Blood · 1997 · 332 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

Scott N. Holden, Sabine Eckhardt, R. Basser et al. · Annals of Oncology · 2005 · 306 citations · Full text

Medicine, Oncology, Pharmacology +15

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer

Kathy D. Miller, José Trigo, Catherine Wheeler et al. · Clinical Cancer Research · 2005 · 197 citations

Medicine, Pharmacology, Pharmacotherapy +17

Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice

Maksim Yezhelyev, Gudrun E. Koehl, Markus Guba et al. · Clinical Cancer Research · 2004 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17